98%
921
2 minutes
20
Cardiac magnetic resonance (CMR) is a key modality for non-invasive extracellular volume (ECV) quantification, typically requiring venous hematocrit (Hct). However, fluctuations in Hct can affect accuracy. This study aimed to develop a synthetic Hct model integrating age, sex, and pre- and post-contrast blood pool T1 values, calibrated against an optimized venous Hct reference. Cardiac MRI data from 253 patients, including those with various pathologies and normal findings, were retrospectively analyzed for ECV calculations. To minimize postural fluctuations, venous Hct samples were taken after the patients remained in a stable supine position for at least 15 min, just before contrast injection. Hct values were derived from pre-contrast and post-contrast T1 mapping sequences. A comprehensive Hct model was developed by integrating age, sex, and both pre- and post-contrast blood pool T1 values. Unlike previous studies, these variables were evaluated collectively, and the model was calibrated using an optimized venous Hct reference. The performance of the derived model at high ECV values was further evaluated in the hypertrophic cardiomyopathy (HCM) subcohort. The Hct model showed strong agreement with measured ECV (bias: 0.31%, RMSE: 1.25, CCC: 0.949). In the HCM subcohort, it maintained high correlation (r = 0.98) with a clinically acceptable bias of - 1.16%. Compared to sex-specific formulas by Chen et al., the model demonstrated improved performance (R² = 0.56) with lower variability. This standardized synthetic Hct model enables accurate, non-invasive ECV estimation without blood sampling and demonstrates superior performance, especially in patients with elevated ECV values.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s10554-025-03504-9 | DOI Listing |
Clin Lymphoma Myeloma Leuk
August 2025
The Mikael Rayaan Foundation Global Transplantation and Cellular Therapy Consortium, Kansas City, KS; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS; U.S Myeloma Innovations Research Collaborative, Kansas City, KS. Electronic addres
Background: Allogeneic hematopoietic stem cell transplantation (allo-HCT) remains the only curative option for myelofibrosis (MF) but is often underutilized in patients aged ≥ 65 due to concerns about treatment-related toxicity.
Methods: We conducted a retrospective analysis of chronic-phase MF allo-HCT recipients using the publicly available CIBMTR P-5640 dataset (2008-2019). Key endpoints included overall survival (OS), disease-free survival (DFS), relapse, nonrelapse mortality (NRM), and graft-vs-host disease (GVHD)-related outcomes.
Naunyn Schmiedebergs Arch Pharmacol
September 2025
Department of Pharmacology, Acharya & BM Reddy College of Pharmacy, Acharya Dr. Sarvepalli Radhakrishna Road, Achit Nagar (Post), Soldevanahalli, Bengaluru, 560107, India.
This study aimed to synthesize and evaluate the anticancer activity of novel chalcone derivative against colon cancer by in vitro cytotoxicity against HCT-116 (Research Resource Identifiers:CVCL_D4JB) cell line and in vivo using EAC (Research Resource Identifiers: CVCL_1306) and DLA (Research Resource Identifiers: CVCL_VR37) cells inoculated Swiss albino mice. The present study aimed to synthesize the new chalcone derivatives and conduct its anti-colon cancer activity both in vitro and in vivo. The designed compounds were subjected to in silico studies like binding pocket analysis, molecular docking, and ADME studies.
View Article and Find Full Text PDFFront Chem
August 2025
Guangzhou Key Laboratory of Formula-Pattern Research Center, School of Traditional Chinese Medicine, The Fifth Affiliated Hospital of Jinan University (Heyuan Shenhe People's Hospital), Jinan University, Guangzhou, China.
Introduction: Colorectal cancer (CRC) is a prevalent malignant tumor of the digestive tract. The FOLFOX regimen (oxaliplatin + calcium folinate + 5-fluorouracil) serves as the primary treatment for advanced CRC clinically, yet its application is significantly limited by substantial toxic side effects. Erianin, a natural compound from Chinese medicine Lindl, demonstrates significant potential in both tumor growth inhibition and chemotherapy toxicity reduction.
View Article and Find Full Text PDFCrit Care Explor
September 2025
Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN.
Objective: To identify distinct phenotypes of acute respiratory distress syndrome (ARDS) developing after hematopoietic cell transplantation (HCT), using routinely available clinical data at ICU admission.
Design: Multicenter retrospective cohort study using latent class analysis.
Setting: ICUs across three Mayo Clinic campuses (Minnesota, Florida, and Arizona).
J Pharmacokinet Pharmacodyn
September 2025
Centre for Applied Pharmacokinetic Research (CAPKR), University of Manchester, Manchester, UK.
Concentration-dependent binding to red blood cells is a characteristic of several drugs, complicating the understanding of how pathophysiological factors influence drug behavior. This study utilized user-friendly, physiologically-based pharmacokinetic (PBPK) models to compare concentration-dependent and independent blood-to-plasma drug concentration ratios (B/P), using tacrolimus as a case study. Two models were developed and validated for tacrolimus using clinical data from healthy volunteers; Model 1 accounted for saturable blood binding, and Model 2 used a constant B/P level.
View Article and Find Full Text PDF